Phasebio Pharmaceuticals Inc raised $40,000,000 on , from Astrazeneca, Hatteras Venture Partners, ....

Get alertedif Phasebio Pharmaceuticals Inc gets funded!
Amount:$40,000,000
Company:
Investors:, , ,
Industry:Biotechnology
Country:
State:
City:
United States
Pennsylvania
Malvern
Key people:Craig A. Rosen (Executive Chairman & CSO)
Susan Arnold (Vice President of Preclinical and Assay Development)
Guy Fish (Board Member, Director)
Lynne Georgopoulos (Senior Vice President of Clinical Development)
M. James Barrett (Board Member)
Asish K. Xavier (Board Member)
Justin Klein (Board Member, Director)
Jonathan Mow (Chief Business Office, Director, Executive Officer)
Christopher Prior (CEO, Director, Executive_Officer)
Joel Sussman (CFO, Executive Officer, Executive_Officer)
Data sources:
startupreport.com - PhaseBio Raises $40 Million Series C Financing Led by AstraZeneca - GlobeNewswire (press release): PhaseBio Raises… http://t.co/Q0zOgdFbWQ
investorshangout.com - News: NASDAQ OMX GlobeNewswire: PhaseBio Raises $40 Million Series C Financing http://t.co/QxkM5hKlWo
www.globenewswire.com - PhaseBio Raises $40 Million Series C Financing Led by AstraZeneca
www.finsmes.com - PhaseBio Pharmaceuticals Secures $40M in Series C #funding http://t.co/k5tp6dkt7k
bit.ly - BioNotebook PhaseBio closes $40m Series C round led by AstraZeneca plus five other VC financings http://t.co/qe2YI7Ucgf
www.scripintelligence.com - RT @ScripMandy: BioNotebook: PhaseBio closes $40m Series C round led by AstraZeneca, plus 5 other VC financings: http://t.co/VDPXfsnwxe (Sc…
ow.ly - News: BioNotebook PhaseBio closes $40m Series C round led by AstraZeneca plus five other VC financings http://t.co/8YqyrXxyDZ
www.vcaonline.com - PhaseBio Raises $40 Million Series C Financing Led by AstraZeneca http://t.co/JXHTIN28no | VCA
musculardystrophynews.com - PhaseBio Raises $40 Million to Advance Clinical Trials for Duchenne's and Becker's Diseases
today.mafiabusiness.com - RT @DisabilityTD: PhaseBio Raises $40 Million to Advance Clinical Trials for Duchenne's and ... - Muscular Dystrophy News - http://t.co/Qq2…
Description:
Phasebio Pharmaceuticals Inc closed 40M for its financing round. Phasebio Pharmaceuticals Inc is specialized in Biotechnology. The date of the round is 2015, March 12th.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!